Literature DB >> 116697

Enzymes of the purine interconversion system in chronic lymphatic leukemia: decreased purine nucleoside phosphorylase and adenosine deaminase activity.

H Ludwig, R Kuzmits, H Pietschmann, M M Müller.   

Abstract

Activities of adenosine deaminase (ADA), adenosine kinase (AK), adenine phosphoribosyltransferase (APRT), hypoxanthine guanine phosphoribosyltransferase (HGPRT), and purine nucleoside phosphorylase (PNP), all enzymes of the purine interconversion system, were determined in lymphocytes of 25 patients with chronic lymphatic leukemia (CLL) and in 23 controls. A statistically significant decrease of PNP activities and a reduction of ADA activities at borderline levels were found in the patients, whereas for the other enzymes assayed no deviation from normal values was observed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 116697     DOI: 10.1007/bf01014193

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  17 in total

1.  Ultramicrochemical studies on enzyme kinetics.

Authors:  M P Uitendaal; C H de Bruyn; T L Oei; P Hösli
Journal:  Adv Exp Med Biol       Date:  1977       Impact factor: 2.622

2.  Adenosine deaminase (ADA) activity in lymphocytes of normal individuals and patients with chronic lymphatic leukaemia.

Authors:  B Ramot; F Brok-Simoni; N Barnea; I Bank; F Holtzmann
Journal:  Br J Haematol       Date:  1977-05       Impact factor: 6.998

3.  Demonstration of adenosine receptor on human lymphocytes in vitro and its possible role in the adenosine deaminase-deficient form of severe combined immunodeficiency.

Authors:  A L Schwartz; R C Stern; S H Polmar
Journal:  Clin Immunol Immunopathol       Date:  1978-04

4.  Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46(2):219-234.

Authors: 
Journal:  Blood       Date:  2016-10-27       Impact factor: 22.113

5.  A specific enzyme defect in gout associated with overproduction of uric acid.

Authors:  W N Kelley; F M Rosenbloom; J F Henderson; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

6.  Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  M S Coleman; J Donofrio; J J Hutton; L Hahn; A Daoud; B Lampkin; J Dyminski
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

7.  A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.

Authors:  H A Simmonds; G S Panayi; V Corrigall
Journal:  Lancet       Date:  1978-01-14       Impact factor: 79.321

8.  Control of pyrimidine biosynthesis in human lymphocytes. Inhibitory effect of guanine and guanosine on induction of enzymes for pyrimidine biosynthesis de novo in phytohemagglutinin-stimulated lymphocytes.

Authors:  K Ito; H Uchino
Journal:  J Biol Chem       Date:  1976-03-10       Impact factor: 5.157

9.  Purine metabolic cycle in normal and leukemic leukocytes.

Authors:  A A Dietz; V Czebotar
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

10.  Adenosine deaminase activity in peripheral blood cells of patients with haematological malignancies.

Authors:  J Meier; M S Coleman; J J Hutton
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

View more
  1 in total

Review 1.  Enzyme and membrane markers in leukaemia: recent developments.

Authors:  A V Hoffbrand; G Janossy
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.